Ariad Pharma (ARIA) Misses Q4 EPS, Revenue Expectations
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $23.99 --0%
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Ariad Pharma (NASDAQ: ARIA) reported Q4 EPS of ($0.38), $0.19 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $78 thousand versus the consensus estimate of $940 thousand.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Netflix (NFLX) bonds retain Outperform rating at Gimme Credit amid strong content ROI
- Citi Reiterates Buy Rating on Yeti Holdings Inc. (YETI)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
